PHV02

BIOLOGICAL2 trials

Sponsors

Public Health Vaccines LLC

Conditions

Nipah Virus Infection

Phase 1

A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

CompletedNCT05178901

Public Health Vaccines LLCNipah Virus Infection

Start: 2022-01-10End: 2023-05-30Updated: 2024-10-24

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

CompletedNCT06221813

Public Health Vaccines LLCNipah Virus Infection

Start: 2024-01-26End: 2024-10-02Updated: 2025-06-08